CRIPTO and non-small cell lung carcinoma: Moreover, ectopic expression of CRIPTO1 in EGFRM+ NSCLC cell lines upregulated ZEB1 and activated the SRC pathway via microRNA-205 (miR-205) downregulation, thereby promoting EMT and erlotinib-resistance of these cells [215].